- Revenue rose slightly to $389.9M (vs $384M in prior year).
- Adjusted diluted EPS jumped to $1.68 from $1.27; GAAP EPS declined to $0.33 from $0.41.
- FDA approved TAUKLARIFY (florquinitau F-18) for Alzheimer's tau PET imaging.
Signal #144538 · SEC 8-K
$LNTH SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $LNTH filing catalyst
Why did $LNTH trigger an AI stock catalyst alert?
$LNTH triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.5/10). Headline: Lantheus Reports Q3: Adj. EPS Rises to $1.68, Revenue at $389.9M, TAUKLARIFY Approved. Key points: - Revenue rose slightly to $389.9M (vs $384M in prior year). - Adjusted diluted EPS jumped to $1.68 from $1.27; GAAP EPS declined to $0.33 from $0.41. - FDA approved TAUKLARIFY (florquinitau F-18) for Alzheimer's tau PET imaging.
How did $LNTH stock react after the SEC filing?
After the SEC 8-K for $LNTH, observed market reaction: T0 price $101.14. Past moves do not guarantee future results.
Where can I get real-time $LNTH SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $LNTH via Telegram and the VIP Web Terminal from €10/month.